THE MOLECULAR GENETICS OF B-CELL MALIGNANCIES CARRYING T(8;14) CHROMOSOMAL TRANSLOCATIONS NLM AIDSLINE Important note: Information in this article was accurate in 1990. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


THE MOLECULAR GENETICS OF B-CELL MALIGNANCIES CARRYING T(8;14) CHROMOSOMAL TRANSLOCATIONS

Diss Abstr Int [B]; 50(7):2766 1990. Unique Identifier : AIDSLINE ICDB/90662262
Haluska FG; Univ. of Pennsylvania


Abstract: The reciprocal chromosome translocation t(8;14), involving the heavy chain locus on chromosome 14 and the c-myc oncogene on chromosome 8 is a characteristic of the B-cell malignancies Burkitt lymphoma, AIDS-associated non-Hodgkin lymphoma (NHL), and acute lymphoblastic leukemia (ALL). Previous molecular analyses of these tumors indicated that a dichotomy exists in the molecular structure of the translocated chromosomes in sporadic and endemic Burkitt lymphomas. The present work utilizes the techniques of molecular cloning and DNA nucleotide sequence analysis to examine the molecular structure of the t(8;14) translocation of one case of ALL, two endemic Burkitt lymphomas, a sporadic case of Burkitt lymphoma, and an AIDS-associated NHL. It is demonstrated that some ALLs and endemic Burkitt lymphomas carry t(8;14) translocations which strongly suggest that the immunoglobulin recombinase enzymes aberrantly function to translocate chromosomes. The translocation junctions were cloned and sequenced. The architecture of the translocations demonstrates (1) breakage of chromosome 8 far 5' of c-myc; (2) breakage of chromosome 14 at J(H) segments; (3) the presence of conserved heptamer-nonamer sequences at the translocation breakpoints; (4) N regions at the breakpoints. These features are consonant with the operation of the immunoglobulin recombinase enzymes. A t(8;14) from a sporadic Burkitt lymphoma with a breakpoint in the region involved in the endemic Burkitt lymphomas was also examined. Despite the location of the breakpoint, the mechanism of translocation in this case implicates the isotype switching process. Taken together with the data from the ALL and endemic Burkitt lymphoma cases, these data suggest that the translocation mechanism correlates with the endemic versus sporadic phenotype of the Burkitt lymphoma. Finally, the t(8;14) translocation from an Epstein-Barr virus-positive AIDS-associated undifferentiated NHL is cloned and sequenced. The features of the translocation junction are shown to be similar to those from endemic cases. Thus it is suggested that the pathogenesis of EBV-positive AIDS-associated Burkitt lymphomas shares essential features with the pathogenesis of endemic Burkitt lymphomas. (Full text available from University Microfilms International, Ann Arbor, MI, as Order No. AAD89-22512)
Keywords: Acquired Immunodeficiency Syndrome/COMPLICATIONS/*GENETICS Burkitt's Lymphoma/*GENETICS Chromosomes, Human, Pair 14 Chromosomes, Human, Pair 8 Genetic Markers Human Leukemia, B-Cell, Acute/*GENETICS Lymphoma, Non-Hodgkin's/COMPLICATIONS/*GENETICS Proto-Oncogenes *Translocation (Genetics) THESISKWDacquiredimmunodeficiencysyndrome/complications/KWDgeneticsburkitt'slymphoma/KWDgeneticschromosomes,human,pair14chromosomes,human,pair8geneticmarkershumanleukemia,b-cell,acute/KWDgeneticslymphoma,non-hodgkin's/complications/KWDgeneticsproto-oncogenesKWDtranslocation(genetics)thesis
900630
M9060636

Copyright © 1990 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1990. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1990. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .